Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $2.62 USD
Change Today -0.05 / -1.87%
Volume 19.5K
CBAY On Other Exchanges
As of 8:10 PM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Harold E. Van Wart Ph.D.

Chief Executive Officer, President and Director,Cymabay Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 25 board members in 2 different organizations across 2 different industries.

See Board Relationships
As of Fiscal Year 2014


Dr. Harold E. Van Wart, Ph.D., has been President at Cymabay Therapeutics, Inc. since 2001 and Chief Executive Officer since 2003. Dr. Van Wart served as Chief Operating Officer of Cymabay Therapeutics, Inc rom May 2001 to January 2003. He joined Cymabay Therapeutics, Inc n October 2000, as Senior Vice President of Research and Development from October 2000 to December 2002. He served as Vice President and Therapy Area Head for Arthritis and Fibrosis Diseases at Roche ...

Read Full Background

Corporate Headquarters*

7999 Gateway Boulevard
Newark, California 94560

United States

Phone: 510-293-8800
Fax: 510-293-9090

Board Members Memberships*

Chief Executive Officer, President and Director
Director and Chairman of Nominating & Corporate Governance Committee


Cornell University
Cornell University
State University of New York at Binghamton

Other Affiliations*

Annual Compensation*

Total Annual Compensation$800,000

Stock Options*

All Other Compensation$12,397
Exercisable Options237,290
Unexercisable Options242,697
Total Number of Options479,987

Total Compensation*

Total Annual Cash Compensation$812,397
Total Short Term Compensation$800,000
Other Long Term Compensation$12,397
Total Calculated Compensation$1,341,712
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CBAY:US $2.62 USD -0.05


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CYMABAY THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at